Loading organizations...
§ Venture Capital · Brazil
Venture capital investor for early-stage and growth-stage companies in technology, biotechnology, life sciences, and industrial sectors.
Caixa Capital Risc is a venture capital firm based in Barcelona, Spain, that manages institutional investment funds focused on early-stage and growth-stage innovative companies. Operating as the primary venture capital arm of its parent company, CriteriaCaixa, the firm targets startups across the technology, biotechnology, life sciences, and industrial sectors throughout Europe and North America. The organization currently manages two specialized investment vehicles, Criteria Venture Tech and Criteria Bio Ventures, maintaining an active portfolio of approximately 40 direct company and fund investments. Over its operational history, the firm has participated in roughly 300 total investments, backing portfolio companies such as the artificial intelligence education platform Growappy, manufacturing software provider Prodsmart, and the exited biotechnology firm BioMimetx. Caixa Capital Risc was officially established in 2007 to formalize the venture capital investment initiatives of its parent financial group.
Key people at Caixa Capital.
Caixa Capital is a venture capital and private equity firm primarily investing in innovative startups and growth-stage companies across information technology, life sciences, and industrial technologies. It operates with a focus on strategic partnerships and long-term value creation, supporting companies from early stages through growth to scale. The firm plays a significant role in the startup ecosystem in Spain and Portugal by backing companies that have gone on to successful exits or acquisitions by global leaders like Facebook and Airbnb[1][6].
Founded in 1991 and headquartered in Lisbon, Caixa Capital is part of the CGD Group and has over 20 years of experience managing venture capital and private equity funds. It has specialized teams dedicated to IT, life sciences, and industrial tech sectors, reflecting an evolution toward sector-focused investment strategies. Over the years, Caixa Capital has made more than 250 investments and collaborated with over 50 national and international venture capital funds, establishing a strong track record in nurturing innovation and scaling startups[1][2][5].
In the broader tech landscape, Caixa Capital rides the wave of digital transformation, biotech innovation, and industrial tech modernization. The timing aligns with increased demand for technological solutions in healthcare, software, and industrial automation, supported by favorable market forces such as growing startup ecosystems in Iberia and rising corporate interest in innovation. Caixa Capital’s influence extends by connecting startups with global markets and facilitating strategic exits, thus strengthening the regional innovation ecosystem[1][6].
Looking ahead, Caixa Capital is poised to deepen its impact by continuing to back cutting-edge startups in high-growth sectors, especially as digital and life sciences technologies evolve rapidly. Trends such as AI integration, biotech advancements, and Industry 4.0 will likely shape its investment focus. Its established network and sector expertise position it well to capitalize on emerging opportunities and further enhance the Iberian Peninsula’s standing as a hub for innovation and technology-driven growth.
This trajectory ties back to Caixa Capital’s mission of fostering innovation through strategic investments and partnerships, reinforcing its role as a key enabler of startup success in its core markets.
Caixa Capital has more than 26 tracked investments across 23 companies. The latest tracked deal is $19.0M Series A in Delox in February 2026.
Key people at Caixa Capital.
